- Home
- BUDA vs COYA Comparison
BUDA vs COYA Comparison
Compare BUDA & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BUDA | COYA |
|---|---|---|
| Founded | 2013 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 91.7M | 102.7M |
| IPO Year | 2025 | 2022 |
Fundamental Metrics
Financial Performance| Metric | BUDA | COYA |
|---|---|---|
| Price | $6.75 | $3.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | $13.00 | ★ $15.21 |
| AVG Volume (30 Days) | 2.8K | ★ 120.8K |
| Earning Date | 11-12-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.07 | N/A |
| Revenue | ★ $12,609,000.00 | $7,945,753.00 |
| Revenue This Year | $35.68 | N/A |
| Revenue Next Year | $21.58 | $387.14 |
| P/E Ratio | $96.79 | ★ N/A |
| Revenue Growth | 11.84 | ★ 123.57 |
| 52 Week Low | $6.25 | $3.71 |
| 52 Week High | $12.00 | $6.62 |
Technical Indicators
Market Signals| Indicator | BUDA | COYA |
|---|---|---|
| Relative Strength Index (RSI) | 52.22 | 27.83 |
| Support Level | $7.42 | N/A |
| Resistance Level | $8.01 | $5.17 |
| Average True Range (ATR) | 0.44 | 0.30 |
| MACD | 0.01 | -0.05 |
| Stochastic Oscillator | 69.60 | 1.99 |
Price Performance
Historical ComparisonAbout BUDA Buda Juice Inc. Common Stock
Buda Juice Inc operates in a beverage industry, focused on fresh, cold-crafted juice production for business-to-business (B2B) distribution. The Company mostly utilizes third-party delivery systems and operates within the State of Texas serving large, national chain grocery stores. It is pioneering a new category in beverages-UltraFresh juice-offering cold-crafted citrus-based drinks that are never heat-treated, pasteurized, never HPP- processed, never UV- treated and always cold.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.